Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
EpimAb Biotherapeutics
company
Funding Round
Series C
Money Raised
$ 120M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| MiraeAsset Financial Group | - | Yes | - | Detail |
| CMB International Capital Corporation | - | Yes | - | Detail |
| Hidragon Capital | - | - | - | Detail |
| Adrian Cheng | - | - | - | Detail |
| Cormorant Asset Management | - | - | - | Detail |
| Decheng Capital | - | - | - | Detail |
| Hony Capital | - | - | - | Detail |
| Octagon Capital Advisors | - | - | - | Detail |
| SDIC Fund Management | - | - | - | Detail |
| Shangbay Capital | - | - | - | Detail |
| Sherpa Venture Capital | - | - | - | Detail |
| Yanchuang Capital | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Apr 24, 2017 | Series A | $ 25M | 3E Bioventures,Decheng Capital,etc. | Detail |
| Jun 5, 2019 | Series B | $ 74M | SDIC Fund Management,Sherpa Venture Capital,etc. | Detail |
